Clinical Trial

A Phase 1 Study of ISM4808 in Healthy Adult Subjects

Name: A Phase 1 Study of ISM4808 in Healthy Adult Subjects — clinical trial record (NCT07415304)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase I, randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), food effect, and QTc effects of single and multiple ascending oral doses of ISM4808 in healthy adult subjects.

Trial Details

NCT Number	NCT07415304
Lead Sponsor	TaiGen Biotechnology Co., Ltd. Collaborators: R&G Pharma Studies Co.,Ltd.
Conditions	Healthy Volunteers
Enrollment	86 participants
Start Date	2026-02-13
Primary Completion	2026-11-30 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-17